The Simcyp Population Based Simulator: Architecture, Implementation, and Quality Assurance
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Developing a user-friendly platform that can handle a vast number of complex physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) models both for conventional small molecules and larger biologic drugs is a substantial challenge. Over the last decade the Simcyp Population Based Simulator has gained popularity in major pharmaceutical companies (70% of top 40 - in term of R&D spending). Under the Simcyp Consortium guidance, it has evolved from a simple drug-drug interaction tool to a sophisticated and comprehensive Model Based Drug Development (MBDD) platform that covers a broad range of applications spanning from early drug discovery to late drug development. This article provides an update on the latest architectural and implementation developments within the Simulator. Interconnection between peripheral modules, the dynamic model building process and compound and population data handling are all described. The Simcyp Data Management (SDM) system, which contains the system and drug databases, can help with implementing quality standards by seamless integration and tracking of any changes. This also helps with internal approval procedures, validation and auto-testing of the new implemented models and algorithms, an area of high interest to regulatory bodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Statistical Analysis of Failure Time Data
Kalbfleisch, J. D., & Prentice, R. L. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781118032985 · Cited by 3,219
General Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug Disposition
Mager, D. E., & Jusko, W. J. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1014414520282 · Cited by 605
The Simcyp ® Population-based ADME Simulator
Jamei, M., Marciniak, S., Feng, K., Barnett, A., Tucker, G., & Rostami-Hodjegan, A. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250802691074 · Cited by 533
Self-citationRostami-Hodjegan, A. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.65 · Cited by 331 · cited 1×
“In Vivo Extrapolation (IVIVE) of Absorption, Distribution, Metabolism and Excretion (ADME) in drug development and regulatory assessment have significantly increased (Zhao et al. 2011, Rostami-Hodjegan 2012).”
BackgroundSelf-citation
Cited by
Shebley, M., Sandhu, P., Emami Riedmaier, A., Jamei, M., Narayanan, R., Patel, A., Peters, S. A., Reddy, V. P., Zheng, M., de Zwart, L., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1013 · Cited by 395
Adiwidjaja, J., Boddy, A. V., & McLachlan, A. J. (2022) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-021-03266-y · Cited by 14
PharmML in Action: an Interoperable Language for Modeling and Simulation
Bizzotto, R., Comets, E., Smith, G., Yvon, F., Kristensen, N., & Swat, M. (2017) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12213 · Cited by 9
Zaph, S., Shtylla, B., Chang, S., Cheng, Y., Gong, J. Q. X., Gulati, A., Hansson, E., Kulesza, A., Ratushny, A. V., Reali, F., et al. (2026) · arXiv · doi:10.48550/arxiv.2604.07811
Metadata
- Authors
- Jamei, M., Marciniak, S., Edwards, D., Wragg, K., Feng, K., Barnett, A., & Rostami-Hodjegan, A.
- Venue
- In Silico Pharmacology
- Published
- 2013-06-03
- Volume
- 1
- Issue
- 1
- Pages
- 9-9
- ISSN
- 2193-9616 (ISSN-L)
- OpenAlex
- W2116310353
- Cited by
- 124
- References
- 4
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Simcyp Population Based Simulator: Architecture, Implementation, and Quality Assurance. https://app.cochat.ai/papers/10.1186/2193-9616-1-9
- The paper
- Jamei, M., Marciniak, S., Edwards, D., Wragg, K., Feng, K., Barnett, A., & Rostami-Hodjegan, A. (2013). The Simcyp Population Based Simulator: Architecture, Implementation, and Quality Assurance. In Silico Pharmacology. https://doi.org/10.1186/2193-9616-1-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.